Updated: Apr 9, 2009
Tibial fractures can now be treated successfully in the majority of patients, yet nonunions of the tibia are not uncommon and may result in significant morbidity, require numerous operative procedures to treat, and leave the patient with functional deficits.
Tibial nonunions are estimated to constitute 2-10% of all tibial fractures. The incidence is greater with high-energy injuries and open fractures. The National Center for Health Statistics has reported that close to 500,000 tibia and fibula fractures occur each year in the United States.
The development of a tibial nonunion is related most often to the type and degree of injury, but several additional factors may predispose a patient to a tibial nonunion, such as the degree of fracture comminution and bone loss, whether the fracture is open, and the degree of soft-tissue injury. Subsequent complications, such as infection or compartment syndrome may play a role.2
In a prospective, observational study of 416 patients from 41 trauma centers operatively treated for tibial shaft fractures, delayed healing or nonunion occurred in 13%. Open fractures with injuries less than 5 cm were 3.6 times as likely to have delayed healing or nonunion as closed fractures; for open fractures greater than 5 cm, the likelihood of delayed healing or nonunion was 5.7 times greater than that for closed fractures. Healing problems were twice as great for distal shaft fractures and fractures with a postoperative diastasis.3
The patient profile also contributes to the incidence of nonunion. Cigarette smoking is well documented to place the patient at a higher risk of delayed healing or nonunion.4 The use of nonsteroidal anti-inflammatory medications may inhibit bone healing, as can the nutritional status of the patient and compliance with the postoperative regimen. Finally, prompt and appropriate treatment is needed because iatrogenic injury to the soft-tissue envelope (ie, excessive periosteal stripping), distraction across the fracture site, inadequate immobilization or fixation, and the splinting effect of an intact fibula may contribute to the development of a nonunion.
Historically, the definition of delayed union and nonunion have been based on time from the onset of injury. More recently, the exact time frames are considered to be less important. Fracture healing is a dynamic, progressive process, and intervention is warranted within 3-5 months after injury if monthly radiographic studies do not show progression of fracture healing.5
Typically, delayed union is a term used for a fracture that has not united within a period of time that would be considered adequate for bone healing. Delayed union suggests that union is slow but will eventually occur without additional surgical or nonsurgical intervention. The time frame is different for different fractures. Tibial diaphyseal fractures that do not show enough bridging callus to achieve clinical stability by 16 weeks are considered to be delayed union fractures.5 Nonunion refers to a fracture that will not unite without additional surgical or nonsurgical intervention (usually by 6-9 mo).
The Weber-Cech classification is the one most widely used.6 Fractures are classified according to radiographic appearance, which correlates with the fracture biology, as follows:
Determining whether evidence of infection is present at the nonunion site is critical.
Paley and Herzenberg classify nonunions according to clinical mobility as the following:
The Paley-Herzenberg categories roughly correlate to the 3 Weber-Cech categories.
Congenital pseudoarthrosis of the tibia is a unique condition observed in children.7,8,9 Neurofibromatosis and fibrous dysplasia are predisposing factors, although some are idiopathic in nature. The pathology seems to lie in the periosteum.
Treatment principles and rationale
The treatment of a tibial nonunion depends of the fracture classification, location of the nonunion, lower extremity alignment, fracture stability, presence of infection, soft-tissue injury (including nerve deficits), and patient characteristics and possible concomitant injuries. A forthright discussion with the patient should be initiated, with the patient's wishes and the physician's experience taken into account.
In general, hypertrophic nonunions are treated with rigid stabilization with or without compression. Additional biologic stimulation in the form of bone grafting is not required.
Atrophic nonunions require augmentation to stimulate bone formation. This may require bone grafting, soft-tissue coverage, or other forms of biologic stimulation, such as bone morphogenetic proteins (BMPs).10
Infected nonunions should be treated in an attempt to sterilize the nonunion site, but stability of the fracture site should not be sacrificed.11
See Pathophysiology.
Contraindications for operative management depend on a number of factors, all of which must be weighed carefully in the decision-making process. The overall health of the patient is critical to the decision-making process. If the patient is critically ill or has undergone multiple previous procedures without success, further treatment may not be possible or may be ill advised. Active infection modifies how and even whether the nonunion is treated. An injury to the neurovascular structures such that the foot is insensate may discourage heroic attempts for treatment of the nonunion. Amputation usually results in a quick return to activities, but it may result in overgrowth at the amputation site in children.
A histologic assessment may be helpful and has been shown to have a high sensitivity (87%) and specificity (100%) when assessing nonunion for the possibility of infection, especially when microbiologic findings are inconclusive.17
Nonoperative methods
Nonoperative methods should always be considered, and although they are rarely considered the definitive treatment, they may be helpful as adjunctive therapy or as a temporizing option.
Treatment principles and rationale
Hypertrophic nonunion
Hypertrophic nonunions display extensive callus formation. These vascular nonunions have excellent healing potential. They are best treated with rigid stabilization with or without compression. Additional biologic stimulation in the form of bone grafting is not required.
Atrophic nonunion
Atrophic nonunions are characterized by an absence of callus, deficient bone vascularity, and poor healing potential. Debridement of all necrotic tissue is necessary, with opposition of viable and vascular bone fragments. In addition, biologic stimulation is required. Historically, this has taken the form of bone grafting, preferably autograft, which is osteogenic, osteoconductive, and osteoinductive. The posterolateral approach usually is preferred to the anterolateral approach because greater space is available for bone grafting and an additional incision through the previous scar is avoided. The posterolateral approach should not be used in proximal-third tibial fractures because of the high risk of injury to the neurovascular structures.
Bone marrow injection has been shown to be an easy and effective treatment. This should be accomplished with the aid of fluoroscopy. Marrow is harvested from the iliac crest and injected directly into the posterior fracture site. In one study, 9 of 11 nonunions healed within 4-23 weeks, without further surgery.24
The use of bone morphogenetic protein (BMP) and other osteoinductive agents has gained increased support experimentally and clinically.10,25,26 With high costs and limited clinical applications, indications are still being determined.27
Surgical treatment
Principles of surgical treatment include the incorporation of the following:
A fibular osteotomy should be used if the fibula is felt to be inhibiting compression across the tibial nonunion site. This is usually performed in combination with other procedures and is used as an isolated procedure only if a stable noninfected hypertrophic nonunion with little or no deformity is present. Usually a small segment of bone is removed (1-2 cm).
Removal of necrotic or infected bone must be performed for a union to occur. This may involve the need for significant bone graft, shortening, or bone transport.
Bony alignment and stability are essential for satisfactory treatment of a tibial nonunion. The use of a reamed intramedullary (IM) nail is an excellent method of treatment of noninfected nonunions, especially in the middle three fifths of the tibia.28 Conversion from a nonreamed nail or plate in closed and grade I or II open fractures with no evidence of infection is the primary indication. This technique has the advantage of early rehabilitation and maintenance of the alignment, and the reaming may act as a bone graft at the fracture site.
Compression plating has also been shown to be effective for treating tibial nonunions. Wiss treated 49 patients with a tibial nonunion after initial external fixation.30 The patients demonstrated a 92% healing rate in a mean of 7 months with no further treatment. Compression plating has the advantage of being applied anywhere along the tibia, and casting is usually unnecessary. However, it may contribute to difficulties with wound healing and can potentially devascularize a segment of bone. Handle the soft tissues in an atraumatic manner. Keep dissection and periosteal stripping to a minimum. Additionally, in patients with poor bone quality, the fixation is less secure. The use of a locking custom blade plate for periarticular nonunions has been described.31
The use of external fixation, especially small-wire and hybrid external fixation, is an excellent option for the treatment of tibial nonunions, especially if the fracture is very proximal or distal (periarticular), if significant bone loss occurred, if deformity (including shortening) is significant, or if ongoing infection is present. The use of external fixation allows for the treatment of multiple issues concurrently. External fixation can provide for stability of the fracture site, even in very proximal or distal fractures, with the use of fine-wire fixation. Large infected bone segments can be removed and grafted, or a shortening can be performed.32
Limb-length equalization can be performed with bone transport or as an isolated procedure after union has occurred. Adjunctive therapy, such as the use of antibiotic bone cement or bone substitute beads, can easily be incorporated, and stabilization with external fixation usually provides for access if soft-tissue grafts are needed.
Most complications that occur in the treatment of nonunions are an extension of the existing condition, but approach all tibial nonunions with great care to avoid making a bad situation worse. Possibly the greatest concern is creating an infected nonunion from an aseptic nonunion. In a 1994 study by Wu, a 13% rate of infection occurred, regardless of treatment technique (ie, compression plating vs IM nailing).33 The conversion from external fixation to IM nailing should be avoided if possible.34 Malalignment, shortening, and continued nonunion may also occur, as well as graft-site morbidity (if autograft is used). Other complications, such as neurovascular injury, compartment syndrome, persistent nonunion, and ultimately amputation, may also result.
Little documentation exists in the literature regarding the functional outcomes of patients treated for tibial nonunions.35 Discussing the potential limitations in future functional abilities with the patient is critical. Fracture healing does not mean full function, and residual weakness, pain, and limitations in function are common, even in appropriately treated patients with clinically successful outcomes.
The use of adjunctive treatment modalities continues to be the most controversial topic, including the need and indication for electrical stimulation, ultrasonography, various synthetic bone osteoconductive carriers, and osteoinductive bone growth factors (such as bone morphogenetic proteins10 ).
Reed LK, Mormino MA. Distal tibia nonunions. Foot Ankle Clin. Dec 2008;13(4):725-35. [Medline].
McQueen MM, Christie J, Court-Brown CM. Acute compartment syndrome in tibial diaphyseal fractures. J Bone Joint Surg Br. Jan 1996;78(1):95-8. [Medline].
Audigé L, Griffin D, Bhandari M, Kellam J, Rüedi TP. Path analysis of factors for delayed healing and nonunion in 416 operatively treated tibial shaft fractures. Clin Orthop Relat Res. Sep 2005;438:221-32. [Medline].
Schmitz MA, Finnegan M, Natarajan R. Effect of smoking on tibial shaft fracture healing. Clin Orthop. Aug 1999;184-200. [Medline].
Wiss DA, Stetson WB. Tibial Nonunion: Treatment Alternatives. J Am Acad Orthop Surg. Oct 1996;4(5):249-257. [Medline].
Weber BG, Cech O. Pseudoarthrosis: Pathology, Biomechanics, Therapy, Results. Berne, Switzerland:. Hans Huber Medical Publisher;1976.
Johnston CE, Birch JG. A tale of two tibias: a review of treatment options for congenital pseudarthrosis of the tibia. J Child Orthop. Mar 2008;2(2):133-49. [Medline].
Martus JE, Johnston CE 2nd. Isolated congenital pseudoarthrosis of the fibula: a comparison of fibular osteosynthesis with distal tibiofibular synostosis. J Pediatr Orthop. Dec 2008;28(8):825-30. [Medline].
Vander Have KL, Hensinger RN, Caird M, Johnston C, Farley FA. Congenital pseudarthrosis of the tibia. J Am Acad Orthop Surg. Apr 2008;16(4):228-36. [Medline].
Valdes MA, Thakur NA, Namdari S, Ciombor DM, Palumbo M. Recombinant bone morphogenic protein-2 in orthopaedic surgery: a review. Arch Orthop Trauma Surg. Mar 12 2009;[Medline].
Emara KM, Allam MF. Ilizarov external fixation and then nailing in management of infected nonunions of the tibial shaft. J Trauma. Sep 2008;65(3):685-91. [Medline].
Puskarich CL, Nelson CL, Nusbickel FR. The use of two nutritional indicators in identifying long bone fracture patients who do and do not develop infections. J Orthop Res. Nov 1990;8(6):799-803. [Medline].
Rainey-Macdonald CG, Holliday RL, Wells GA, Donner AP. Validity of a two-variable nutritional index for use in selecting candidates for nutritional support. JPEN J Parenter Enteral Nutr. Jan-Feb 1983;7(1):15-20. [Medline].
Chan YL, Liao HC, Tsay PK. C-reactive protein as an indicator of bacterial infection of adult patients in the emergency department. Chang Gung Med J. Jul 2002;25(7):437-45. [Medline].
Mason MD, Zlatkin MB, Esterhai JL, Dalinka MK, Velchik MG, Kressel HY. Chronic complicated osteomyelitis of the lower extremity: evaluation with MR imaging. Radiology. Nov 1989;173(2):355-9. [Medline].
Nepola JV, Seabold JE, Marsh JL. Diagnosis of infection in ununited fractures. Combined imaging with indium-111-labeled leukocytes and technetium-99m methylene diphosphonate. J Bone Joint Surg Am. Dec 1993;75(12):1816-22. [Medline].
Simpson AH, Wood MK, Athanasou NA. Histological assessment of the presence or absence of infection in fracture non-union. Injury. Mar 2002;33(2):151-5. [Medline].
Sarmiento A, Burkhalter WE, Latta LL. Functional bracing in the treatment of delayed union and nonunion of the tibia. Int Orthop. 2003;27(1):26-9. [Medline].
Brighton CT, Shaman P, Heppenstall RB, et al. Tibial nonunion treated with direct current, capacitive coupling, or bone graft. Clin Orthop. Dec 1995;(321):223-34. [Medline].
Guerkov HH, Lohmann CH, Liu Y, Dean DD, Simon BJ, Heckman JD, et al. Pulsed electromagnetic fields increase growth factor release by nonunion cells. Clin Orthop Relat Res. Mar 2001;265-79. [Medline].
Griffin XL, Warner F, Costa M. The role of electromagnetic stimulation in the management of established non-union of long bone fractures: what is the evidence?. Injury. Apr 2008;39(4):419-29. [Medline].
Khan Y, Laurencin CT. Fracture repair with ultrasound: clinical and cell-based evaluation. J Bone Joint Surg Am. Feb 2008;90 Suppl 1:138-44. [Medline].
Busse JW, Bhandari M, Kulkarni AV. The effect of low-intensity pulsed ultrasound therapy on time to fracture healing: a meta-analysis. CMAJ. Feb 19 2002;166(4):437-41. [Medline].
Sim R, Liang TS, Tay BK. Autologous marrow injection in the treatment of delayed and non-union in long bones. Singapore Med J. Oct 1993;34(5):412-7. [Medline].
Heckman JD, Boyan BD, Aufdemorte TB. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg Am. Jun 1991;73(5):750-64. [Medline].
Vaccaro AR, Chiba K, Heller JG. Bone grafting alternatives in spinal surgery. Spine J. May-Jun 2002;2(3):206-15. [Medline].
Dahabreh Z, Calori GM, Kanakaris NK, Nikolaou VS, Giannoudis PV. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. Int Orthop. Dec 4 2008;[Medline].
Wu CC, Shih CH, Chen WJ, Tai CL. High success rate with exchange nailing to treat a tibial shaft aseptic nonunion. J Orthop Trauma. Jan 1999;13(1):33-8. [Medline].
[Best Evidence] Bhandari M, Guyatt G, Tornetta P 3rd, Schemitsch EH, Swiontkowski M, Sanders D, et al. Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures. J Bone Joint Surg Am. Dec 2008;90(12):2567-78. [Medline].
Wiss DA, Johnson DL, Miao M. Compression plating for non-union after failed external fixation of open tibial fractures. J Bone Joint Surg Am. Oct 1992;74(9):1279-85. [Medline].
Harvey EJ, Henley MB, Swiontkowski MF. The use of a locking custom contoured blade plate for peri-articular nonunions. Injury. Feb 2003;34(2):111-6. [Medline].
Rozbruch SR, Pugsley JS, Fragomen AT, Ilizarov S. Repair of tibial nonunions and bone defects with the Taylor Spatial Frame. J Orthop Trauma. Feb 2008;22(2):88-95. [Medline].
Wu CC, Shih CH. Comparison of dynamic compression plating and reamed intramedullary nailing in the treatment of aseptic tibial shaft nonunions. Contemp Orthop. Jan 1994;28(1):28-33. [Medline].
Törnqvist H. Tibia nonunions treated by interlocked nailing: increased risk of infection after previous external fixation. J Orthop Trauma. 1990;4(2):109-14. [Medline].
Gardner MJ, Toro-Arbelaez JB, Hansen M, Boraiah S, Lorich DG, Helfet DL. Surgical treatment and outcomes of extraarticular proximal tibial nonunions. Arch Orthop Trauma Surg. Aug 2008;128(8):833-9. [Medline].
Court-Brown CM, McQueen MM. High success rate with exchange nailing to treat tibial shaft aseptic nonunion. J Orthop Trauma. May 1999;13(4):274. [Medline].
Dumont AS, Verma S, Dumont RJ, Hurlbert RJ. Nonsteroidal anti-inflammatory drugs and bone metabolism in spinal fusion surgery: a pharmacological quandary. J Pharmacol Toxicol Methods. Jan-Feb 2000;43(1):31-9. [Medline].
Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 2):S151-8. [Medline].
Kuhlman JE, Fishman EK, Magid D, et al. Fracture nonunion: CT assessment with multiplanar reconstruction. Radiology. May 1988;167(2):483-8. [Medline].
McQueen MM, Christie J, Court-Brown CM. Compartment pressures after intramedullary nailing of the tibia. J Bone Joint Surg Br. May 1990;72(3):395-7. [Medline].
McQueen MM, Court-Brown CM. Compartment monitoring in tibial fractures. The pressure threshold for decompression. J Bone Joint Surg Br. Jan 1996;78(1):99-104. [Medline].
Paley D, Catagni MA, Argnani F, et al. Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop. Apr 1989;(241):146-65. [Medline].
tibial nonunion, tibial delayed union, aseptic nonunion, infected nonunion, tibial fractures, fractures of the tibia, fractured tibia, nonunions of the tibia, broken leg, leg fracture, delayed healing, hypertrophic nonunions, atrophic nonunions, normotrophic nonunions, long bone fractures, bone morphogenic protein, bone morphogenetic protein, BMP
Minoo Patel, MBBS, MD, MS, FRACS, Senior Lecturer, Monash University; Consulting Adult/Pediatric Orthopedic Surgeon, Department of Orthopedic Surgery, Monash Medical Center, Australia
Minoo Patel, MBBS, MD, MS, FRACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, AO Foundation, Australian Association of Surgeons, Australian Medical Association, Australian Orthopaedic Association, Orthopaedic Research Society, Orthopaedics Overseas, Pediatric Orthopaedic Society of North America, and Royal Australasian College of Surgeons
Disclosure: Nothing to disclose.
James J McCarthy, MD, FAAOS, FAAP, Associate Professor, Consulting Orthopedic Surgeon, Department of Orthopedics and Rehabilitation, University of Wisconsin School of Medicine and Public Health;
James J McCarthy, MD, FAAOS, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Orthopaedic Surgeons, American Academy of Pediatrics, American Orthopaedic Association, Limb Lengthening and Reconstruction Society ASAMI-North America, Orthopaedics Overseas, Pediatric Orthopaedic Society of North America, Pennsylvania Medical Society, Pennsylvania Orthopaedic Society, and Philadelphia County Medical Society
Disclosure: Nothing to disclose.
John Herzenberg, MD, FRCSC, Head of Pediatric Orthopedics, Co-director of International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore
John Herzenberg, MD, FRCSC is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine, American Academy of Orthopaedic Surgeons, Limb Lengthening and Reconstruction Society ASAMI-North America, and Pediatric Orthopaedic Society of North America
Disclosure: Nothing to disclose.
Charles T Mehlman, DO, MPH, Director, Musculoskeletal Outcomes Research, Associate Professor, Division of Pediatric Orthopedic Surgery, Cincinnati Children's Hospital Medical Center
Charles T Mehlman, DO, MPH is a member of the following medical societies: American Academy of Pediatrics, American Fracture Association, American Medical Association, American Orthopaedic Foot and Ankle Society, American Osteopathic Association, Arthroscopy Association of North America, North American Spine Society, Ohio State Medical Association, Pediatric Orthopaedic Society of North America, and Scoliosis Research Society
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Thomas M DeBerardino, MD, Director, John A Feagin, Jr, Sports Medicine Fellowship at West Point, Associate Professor of Orthopedic Surgery, Uniformed Services University of the Health Sciences and Keller Army Community Hospital
Thomas M DeBerardino, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Association, and American Orthopaedic Society for Sports Medicine
Disclosure: Arthrex, Inc. Grant/research funds None; Arthrex, Inc. Honoraria Speaking and teaching; Genzyme Biosurgery. Inc. Grant/research funds Other; Musculoskeletal Transplant Foundation Grant/research funds Other; Histogenics Grant/research funds None
Dinesh Patel, MD, FACS, Associate Clinical Professor of Orthopedic Surgery, Harvard Medical School; Chief of Arthroscopic Surgery, Department of Orthopedic Surgery, Massachusetts General Hospital
Dinesh Patel, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Physicians of Indian Origin, American College of International Physicians, and American College of Surgeons
Disclosure: Nothing to disclose.
Carlos J Lavernia, MD, FAAOS, Adjunct Clinical Professor, Department of Orthopedic Surgery, University of Miami School of Medicine; Medical Director, Orthopedic Institute at Mercy Hospital
Carlos J Lavernia, MD, FAAOS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Hip and Knee Surgeons, Arthritis Foundation, Biomedical Engineering Society, Florida Orthopaedic Society, and Orthopaedic Research Society
Disclosure: Zimmer Stock Implant Designer
Related eMedicine topics
Tibia Fractures, Open
Lower Extremity Reconstruction, Tibia
Tibial Shaft Fractures
Diaphyseal Tibial Fractures
Fracture, Tibia and Fibula
Clinical trials
A Prospective Randomized Controlled Trial on the Use of Bone Morphogenetic 7 (BMP-7) (OP-1®) and Demineralized Bone Matrix in Tibial Non-Union
A Randomized Controlled Cost Study of Infuse BMP 2 vs Iliac Crest Autograft for Non Union of Long Bone Fractures
rhBMP-2 Versus Autograft in Critical Size Tibial Defects
A Phase 2/3 Multicenter, Controlled Trial of rhBMP-2/CPM in Tibial Fractures
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)